<DOC>
	<DOCNO>NCT02988791</DOCNO>
	<brief_summary>Infantile colic ( IC ) criterion include follow subject age ≤ 4 month : paroxysms irritability , fussing , cry start stop without obvious cause ; episodes last 3 hour per day occur least 3 day per week least 1 week ; failure thrive . The condition common first 4 month life ( 10-30 % infant ) peak prevalence 6-8 week characterize excessive inconsolable cry without identifiable cause . Infantile colic cause considerable stress baby family , huge medical expense ( IC cause 10-20 % pediatric visit first 4 month life ) frequent formula change . The pathophysiology IC still poorly define , difference gut microbiota composition seem involve . In particular , difference number specie Lactobacilli spp , Klebsiella spp Escherichia coli spp demonstrate subject IC , postulate alteration could responsible abnormal gas production within gut lumen result distension abdominal pain . These finding suggest potential role probiotic preventive therapeutic strategy IC .</brief_summary>
	<brief_title>Evaluation Probiotic ( Bifidobacterium Treatment Infantile Colic ( IC )</brief_title>
	<detailed_description />
	<mesh_term>Colic</mesh_term>
	<criteria>exclusively breastfed healthy infant sex , age ≤ 7 week ; Diagnosis IC accord Rome III criterion Written inform consent parent/tutor Birth weight &lt; 2500 g Gestational age &lt; 37 week APGAR 5 minute &lt; 7 Formula feed Abnormal body growth/loss weight ( &lt; 100 g/weeks birth last report weight ) Neurological diseases Known suspect food allergy Gastroesophageal reflux disease Use substances alter gut microbiota ( pre/pro/synbiotic , antibiotic , gastric acidity inhibitor ) anticolic drug last 2 week prior enrollment History fever and/or infectious disease last 2 week prior enrollment Ongoing systemic infection History congenital infection Chronic intestinal disease ( cystic fibrosis form pancreatic insufficiency primitive ) Malformation gastrointestinal ( esophageal atresia , intestinal atresia , short bowel syndrome , malrotation ) , urinary respiratory tract Metabolic diseases Genetic disease chromosomal abnormality Primary secondary immunodeficiency Not sufficient reliability presence condition may result noncompliance/adherence patient Protocol Previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Weeks</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>